N-Methyl -4 -phenyl -1,2,3,6 -tetrahydropyridine (MPTP) produces neuropathological and clinical abnormalities in humans, monkeys, and mice that closely resemble idiopathic parkinsonism. N-Methyl-4-phenylpyridine (MPP+), a metabolite of MPTP formed by monoamine oxidase B, is accumulated into striatal and cerebral cortical synaptosomes by the dopamine and norepinephrine uptake systems, respectively, whereas MPTP itself is not accumulated. N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a by-product of the chemical synthesis of an analog of the opiate meperidine. In humans MPTP produces apparently irreversible symptoms clinically similar to those found in parkinsonism (1) (2) (3) (4) . After MPTP administration to humans, monkeys, and mice, pathological lesions and neurochemical changes are prominent in nigrostriatal dopaminergic neurons (1-11), although other catecholaminergic neurons are also affected (5, 7, 10) .
N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a by-product of the chemical synthesis of an analog of the opiate meperidine. In humans MPTP produces apparently irreversible symptoms clinically similar to those found in parkinsonism (1) (2) (3) (4) . After MPTP administration to humans, monkeys, and mice, pathological lesions and neurochemical changes are prominent in nigrostriatal dopaminergic neurons (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , although other catecholaminergic neurons are also affected (5, 7, 10) .
MPTP neurotoxicity is dependent on its conversion by monoamine oxidase B (MAO B) to N-methyl-4-phenylpyridine (MPP+) (12, 13) . Deprenyl or pargyline, selective MAO B inhibitors, block the conversion of MPTP to MPP+ in brain mitochondrial preparations (14) . Pretreatment of mice (15) and monkeys (16) with MAO inhibitors prevents the neurotoxic action of MPTP.
[3H]MPTP binds with high affinity to receptor-like sites that reflect the initial recognition sites for the neurotoxic process (17) . Thus, the chemical specificity of the binding sites parallels the ability to elicit neurotoxicity (17) . Also, [3H]MPTP binding sites are concentrated in human substantia nigra and caudate, whereas these regions have substantially fewer binding sites in rats (17) , in accordance with the lesser neurotoxicity of MPTP in this species (18) (19) (20) (21) (22) (17, 23, 24) as well as the localization of MAO B determined immunohistochemically (25, 26) . Moreover, the potencies of selective MAO B inhibitors in competing for [3H]MPTP binding are similar to their potencies as MAO inhibitors (17, 24) . Thus, MPTP binding sites appear to reflect MAO B.
While levels of MAO B are high in human substantia nigra and caudate, MAO B also occurs in numerous other parts of the brain (17, (23) (24) (25) (26) , and thus MPP+ is formed from MPTP throughout the brain (12, 13) . Accordingly, though the selective binding of MPTP and production of MPP+ by MAO B is a necessary first step in eliciting toxicity, it cannot account for the selective effects on catecholamine neurons.
In a preliminary study, we showed that [3H]MPP+, but not [3H]MPTP, is accumulated via the dopamine neuronal uptake system (27) . This report describes how both the dopamine and norepinephrine uptake systems transport 6 min the uptake was terminated by the addition of 4 ml of ice-cold buffer to each tube and filtration of the mixture through glass-fiber filters (Schleicher & Schuell no. 32). Filters were washed with two consecutive 2-ml aliquots of buffer. Radioactivity remaining on the filters was measured by liquid Abbreviations: MPTP, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, N-methyl-4-phenylpyridine; MAO, monoamine oxidase. §To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. scintillation spectrometry. To correct for passive diffusion and adsorption to membranes and filters, control samples were incubated in the presence of 10 ,uM mazindol. Active uptake was calculated by subtracting from the total cpm the number of cpm accumulated in the presence of 10 gM mazindol and was expressed as nmol per g of tissue per min.
Km, Vmax, and Ki values were calculated from saturation and drug competition data by using an iterative curve-fitting program (28) .
Autoradiographic studies of accumulated [3H]MPP+ utilized 300-,um coronal sections of rat brain cut with a Vibratome. The sections were incubated for 30 min at 370C in uptake buffer with 5 nM [3H]MPP+. The sections were washed twice for 5 min in uptake buffer, then placed on glass slides and frozen on dry ice. The slides were dried under reduced pressure and then apposed to tritium-sensitive film (3H-Ultrofilm, LKB) for 2 days at 40C (29) . Autoradiographic studies with [3H]mazindol used slide-mounted mouse brain sections as described previously (30) . The binding of [3H]mazindol to striatal homogenates was assayed as described (31 (Fig. 2) . Uptake in slices is sodium dependent and potently inhibited in the corpus striatum by mazindol but not by desipramine or citalopram (data not shown). (Table  2 ). In addition, mazindol (10 mg/kg), a potent inhibitor of dopamine and norepinephrine uptake, given 30 min prior to each daily injection of MPTP, also prevents MPTP neurotoxicity. By contrast, similar treatment with desipramine, which blocks norepinephrine but not dopamine uptake, fails to prevent MPTP toxicity in the corpus striatum.
DISCUSSION
The present findings provide a model to explain the parkinsonism-like MPTP neurotoxicity (Fig. 4) . MPTP for their selective destruction. The prevention of MPTPinduced damage to the nigrostriatal dopaminergic neurons of mice by the dopamine uptake blocker mazindol demonstrates the requirement of MPP+ transport for neurotoxicity.
Immunohistochemical studies have localized MAO B to rat brain astrocytes and serotonin-containing but not catecholaminergic neurons (25, 26 Male C57BL mice were injected once daily for 7 days with MPTP (30 mg/kg) or saline. Thirty minutes prior to this injection mice received mazindol (10 mg/kg), pargyline (10 mg/kg), desipramine (10 mg/kg), or saline. Seven days after the last drug treatment, the mice were killed by cervical dislocation and the corpora striata were assayed for [3H]mazindol binding as described previously (31) .
[3H]Mazindol (5 nM) was incubated with striatal membranes in the presence of 300 mM NaCl. Values represent mean + SD of (n) determinations. *P < 0.001 compared with saline control.
thousandfold above the extracellular concentration (36) . Exactly how MPP+ then damages dopamine neurons is unclear. MPP+ is cytotoxic (37) and can interfere with mitochondrial respiration (38) .
The caudate-putamen, nucleus accumbens, and locus ceruleus contain the highest number and density of catecholamine uptake sites in the brain (30) . Thus, the enhancement by MPTP of 2-deoxyglucose accumulation into the substantia nigra, the ventral tegmental area containing the cell bodies of those dopamine neurons terminating in the nucleus accumbens, and the locus ceruleus (39) corresponds with the regions expected to accumulate MPP+ most avidly. The accumulation of MPP+ by noradrenergic neurons fits with the marked effects of MPTP on norepinephrine metabolism both in the brain (5, 7, 10) and in the peripheral sympathetic nervous system (10) . The differences in the regional density of catecholamine uptake coupled with regional differences in MAO B density can account for the specific pattern of neuronal degeneration seen in primates. Alternatively, the mesolimbic dopamine neurons are less sensitive to the toxic action of intraneuronal MPP+.
It has been suggested that environmental toxins similar to MPTP cause idiopathic parkinsonism (42) . The accumulation of MPP+ into norepinephrine neurons and into mesolimbic dopaminergic neurons has bearing on these speculations, since in idiopathic parkinsonism, norepinephrine neurons in the locus ceruleus and dopamine neurons in the ventral tegmental areas as well as the substantia nigra are affected (43) (44) (45) .
